More than 100,000 women have filed lawsuits against mesh manufacturers for their injuries, resulting in multimillion dollar verdicts and more than $1 billion in settlements. In 2011, the FDA reported receiving 4,000 adverse event reports caused by transvaginal mesh in the previous six years. In 2016, the FDA changed the classification of transvaginal mesh used to repair POP from a moderate-risk device to a high-risk device. The FDA orders apply only to transvaginal use of surgical mesh to treat POP, and not to the use of transvaginal mesh for SUI. (https://www.nwhn.org/i-was-diagnosed-with-pelvic-organ-prolapse-pop-what-are-the-side-effects-of-a-vaginal-pelvic-mesh-treatment/). “If you wish to find more information on transvaginal mesh, the FDA publishes information about transvaginal mesh and its risks on their website, and there are several transvaginal mesh patient advocacy groups as well as publications such as Public Citizen and Mesh Medical News Desk, which serve to educate the public about the risks of mesh and also information about safer alternatives.  ” (https://www.nwhn.org/i-was-diagnosed-with-pelvic-organ-prolapse-pop-what-are-the-side-effects-of-a-vaginal-pelvic-mesh-treatment/).